A polymorphism of the enzyme CYP2C19 affects the response to clopidogrel .
Decreasing enzymatic activity and therefore reducing the active metabolite of clopidogrel .
A polymorphism of the enzyme CYP2C19 affects the response to clopidogrel hence decreasing enzymatic activity and therefore reducing the active metabolite of clopidogrel .